Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of the effects of enoximone on chemoreceptor sensitivity
2006-004066-14Phase 4Completed
- Sponsor
- Erasmus Hospital
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of enoximone (2 arms), sponsored by Erasmus Hospital. Primary endpoint: Change in chemoreflex sensitivity with enoximone. Started Jul 2006; status: completed.
02
Drugs
enoximone
Beyond the preview
Go deeper on 2006-004066-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004066-14.